Showing results (5621-5630 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|February 13, 2024
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical TrialsJonathon Vallejo, Harpreet Singh, Erin Larkins, et al.
The Oncologist|February 23, 2024
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMISNeal D Shore, Christian Gratzke, Susan Feyerabend, et al.
The Oncologist|January 27, 2024
Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the USXiaoqin Yang, Enrico Zanardo, Dominique Lejeune, et al.
The Oncologist|July 24, 2023
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast CancerHope S Rugo, Xianchen Liu, Benjamin Li, et al.
The Oncologist|August 9, 2023
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399Ryan D Gentzler, Liza C Villaruz, John C Rhee, et al.
The Oncologist|April 16, 2024
Comorbidity profiling identifies potential subtype of elderly patients with nasopharyngeal carcinomaYing Li, Yuhui Pan, Zongwei Huang, et al.
The Oncologist|May 7, 2024
From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient viewsMegan C Best, Phyllis Butow, Jacqueline Savard, et al.
The Oncologist|April 24, 2024
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 ImmunotherapyDylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, et al.
The Oncologist|April 26, 2024
Perception of Polish patients with cancer of the ethical and legal issues related to biobank researchJan Domaradzki, Justyna Czekajewska, Dariusz Walkowiak
The Oncologist|April 30, 2024
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviorsRaffaele Giusti, Giampiero Porzio, Marco Maltoni, et al.
Pageof 571